Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Active Not Recruiting NCT07179978

Lorazepam and the Risk of Serious Adverse Events

Conditions: Chronic Kidney Disease (CKD)

Sex: All

Ages: 66 Years – N/A

Healthy volunteers: No

Enrollment: 12308

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Location: London Health Sciences Centre Research Institute London Ontario

Summary

This is a population-based cohort study assessing whether initiating a new outpatient prescription of a higher dose of lorazepam (\>1-4 mg/day) compared to a lower dose (0.5-1 mg/day) in older adults with low kidney function (an eGFR \

Eligibility Criteria

Inclusion Criteria: The cohort will include older adults aged 66 years or greater with low kidney function (an eGFR \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07179978). StuddyBuddy aggregates publicly available trial information.